CU Boulder researchers have identified a surprising new player in ALS (amyotrophic lateral sclerosis)—an ancient, virus-like protein. With funding from the ALS Association, the National Institutes of Health, and Venture Partners at CU Boulder, Alexandra Whiteley's lab is now working to understand the molecular pathways involved and to find a way of inhibiting the rogue protein.